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Findings in humans and animal models suggest that in utero hormonal and dietary exposures increase later breast cancer risk. Since
alcohol intake by adult women consistently increases their breast cancer risk, we wondered whether maternal alcohol consumption
during pregnancy increases female offspring’s mammary tumorigenesis. In our study, pregnant female rats were pair-fed isocaloric
diets containing either 0 (control), 16 or 25g alcoholkg
 1 feed between days 7 and 19 of gestation. These alcohol exposures
generate blood alcohol levels that correspond to low and moderate alcohol consumption and are lower than those that induce foetal
alcohol syndrome. Serum oestradiol levels were elevated in pregnant rats exposed to alcohol (Po0.003). When adult, female
offspring of alcohol-exposed dams developed significantly more 7,12-dimethylbenz[a]anthracene -induced mammary tumours,
compared to the controls (tumour multiplicity; mean7s.e.m., controls: 2.070.3, 16g alcohol: 2.770.4 and 25g alcohol: 3.770.4;
Po0.006). In addition, the mammary epithelial tree of the alcohol-exposed offspring was denser (Po0.004) and contained more
structures that are susceptible for the initiation of breast cancer (Po0.001). Immunohistochemical assessment indicated that the
mammary glands of 22-week-old in utero alcohol-exposed rats contained elevated levels of oestrogen receptor-a (Po0.04) that is
consistent with the changes in mammary gland morphology. In summary, maternal alcohol intake during pregnancy increases female
offspring’s mammary tumorigenesis, perhaps by programming the foetal mammary gland to exhibit persistent alterations in
morphology and gene expression. It remains to be determined whether an increase in pregnancy oestradiol levels mediated alcohol’s
effects on offspring’s mammary tumorigenesis.
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Some breast cancers may be pre-initiated in utero following an
exposure to elevated maternal oestrogen levels that stimulate the
growth of foetal mammary gland and might cause long-lasting
alterations in the expression of oestrogen-regulated genes (Tri-
chopoulos, 1990; Hilakivi-Clarke et al, 2002). Our goal has been to
identify factors that modify pregnancy oestrogen levels and
daughter’s breast cancer risk. These studies have to be performed
first using animal models that mimic human breast cancer, since it
is difficult to examine interactions between in utero exposures and
breast cancer that is detected several decades later in women.
One factor that might modify pregnancy hormone levels is diet:
for example, maternal intake of a high-fat n-6 polyunsaturated
fatty acid diet increases both pregnancy oestradiol (E2) levels and
carcinogen-induced mammary tumorigenesis among female off-
spring, mimicking the effects seen when pregnant dams are treated
with E2 (Hilakivi-Clarke et al, 1997b). Another dietary factor that
might modify pregnancy E2 levels is alcohol. Alcohol intake
increases serum oestrogen levels (Hankinson et al, 1995), possibly
by stimulating aromatase activity (Purohit, 2000), and alcohol has
been consistently linked to increased risk of developing breast
cancer (Smith-Warner et al, 1998; Singletary and Gapstur, 2001;
Hamajima et al, 2002). Studies in humans indicate that mothers
reporting having consumed some alcohol during pregnancy have
higher pregnancy E2 levels than women who do not drink any
alcohol during pregnancy (Petridou et al, 1992; Wuu et al, 2002). It
is not known, however, whether alcohol exposure in utero through
a pregnant mother increases later breast cancer risk (Stevens and
Hilakivi-Clarke, 2001).
The aim of our study was to determine whether maternal alcohol
exposure increases pregnancy E2 levels and female offspring’s risk
of developing mammary tumours in rats. In addition, we studied
possible changes in the mammary gland morphology and
expression of oestrogen receptor (ER)-a. These receptors mediate
the effects of oestrogens on the breast, through a complex
signalling network, and are clearly involved in the mammary
gland development (Saji et al, 2000). Findings in vitro indicate that
alcohol increases ER-a expression in human breast cancer cells
(Fan et al, 2000; Singletary et al, 2001). Further, earlier human
studies have shown that high alcohol intake is linked to increased
Received 28 October 2003; revised 23 February 2004; accepted 24
February 2004; published online 11 May 2004
*Correspondence: Dr L Hilakivi-Clarke, Georgetown University, NRB,
Lombardi Cancer Center, Research Building, Room W405, 3970
Reservoir Road, NW, Washington, DC 20057-2197, USA;
E-mail: clarkel@georgetown.edu
4Both authors contributed equally to the study
British Journal of Cancer (2004) 90, 2225–2231

























smammographic density (Vachon et al, 2000) that in turn is
associated with increased breast cancer risk (Boyd et al, 2001).
Findings in animal studies also suggest that alcohol modifies
mammary gland development (Singletary et al, 1991). The goal of
our study was to determine whether alcohol exposure during
pregnancy might increase mammary gland ER-a levels, epithelial
density and number of epithelial targets for malignant transforma-
tion (terminal end buds (TEBs)).
METHODS
Maternal alcohol exposure
Pregnant Sprague–Dawley rats were obtained from Charles River
on day 7 of gestation. The rats were housed individually in
standard rat plexiglas cages, at a constant temperature and
humidity, under a 12-h light–dark cycle (lights on 0600h). All
the experiments reported in this manuscript were carried out with
the appropriate institutional ethical committee approval and they
met the standards of both the US federal regulations and those
required by the UKCCCR guidelines (Workman et al, 1998).
To examine whether maternal alcohol intake affects pregnancy
oestrogen levels and offspring’s mammary tumorigenesis, the rats
were divided into three groups (n¼15 per group) upon arrival on
gestation day 7, and were pair-fed isocaloric liquid diets containing
either 0 (control), 16g (low, 7% alcohol of total energy) or 25g
(moderate, 15% alcohol of total energy) alcoholkg
 1 feed (Work-
man et al, 1998). Other ingredients of the diets were Premix, oil,
maltose-dextrin, and deionised water. Diet ingredients were
provided by Research Diets, Inc., New Brunswick, N. J. Pre-mix
contained the following ingredients (given as gl
 1): casein (41.4),
DL-methionine (0.3), L-cystine (0.5), cellulose (10), xanthan gum
(3), complete mineral mix (8.75), complete vitamin mix (2.5) and
choline bitartrate (0.53). The oil mix contained corn oil (8.5), olive
oil (28.4) and safflower oil (2.7) The control diet also had 115.2g of
maltodextrin, and the alcohol-containing diets had an amount of
maltodextrin removed equivalent to the calories of the added
alcohol. Diets were prepared twice a week using a commercial
blender.
We did not determine blood alcohol levels (BAL) in this
experiment, but were able to estimate them based on previous
studies that used identical diets used here (Vavrousek-Jakuba et al,
1991; Catlin et al, 1993; Baker and Shoemaker, 1995). Our
estimates were also based on the linearity of BAL following
administration of different levels of alcohol. According to these
estimates, BAL for the rats receiving the 16g alcohol kg diet is
61.375.0mgdl
 1, and for the 25g alcohol kg diet is
95.876.1mgdl
 1. These BAL are similar to those seen in low-to-
modest alcohol drinkers, respectively, and lower than those found
to induce foetal alcohol syndrome (FAS) (Singletary and Gapstur,
2001).
Since alcohol intoxication might disrupt normal labour and care
of newborn pups, we withdrew pregnant rats from alcohol on
gestation day 19. All the animals were fed AIN93 diets from that
point onwards.
Effects on pregnancy oestrogen levels
On gestation day 19, blood was obtained by cardiac puncture to
determine circulating 17b-oestradiol (E2) levels in dams fed 0
(control), 16 or 25g alcohol per kg feed between gestation days 7
and 19. For that purpose, a specific double antibody kit from ICN
Biomedicals, Inc. (Irvine, CA, USA) was used following the
manufacturer’s instructions. To avoid any cross-reactivity with
other serum components, E2 was extracted from serum using a
mixture of organic solvents.
Mammary gland morphology
The mechanisms mediating the effects of in utero exposures on
later risk of developing breast cancer could include changes in the
mammary gland morphology and expression of genes regulating it.
Therefore, wholemounts of the fourth abdominal glands, obtained
at different ages and processed as previously described (Hilakivi-
Clarke et al, 1997a, b), were assessed for changes in the
morphology (Workman et al, 1998). The relative densities of
epithelial tree, alveolar buds and lobules were determined in the 8-
and 22-week-old rats using a five-point visual scale (from:
0¼absent, to 5¼numerous) we have previously validated
(Hilakivi-Clarke et al, 1997a). The total number of TEBs was
counted in 3-, 6-and 8-week-old offspring; that is, at times when
their number is at the highest and before they differentiate to
lobular–alveolar structures. Identification of each of the epithelial
structures was based on the guidelines of mammary gland
morphology by Russo and Russo (1987). All the analyses were
done double-blinded under an Olympus dissecting microscope.
Oestrogen receptors
We determined ER-a expression in the mammary glands of 22-
week-old rats by immunocytochemistry using MC-20 antibody for
ER-a (rabbit polyclonal IgG, Santa Cruz Biotechnology, CA, USA)
at 1:100 dilution. The level of expression was assessed in three
ductal and three lobular structures per section. Oestrogen
receptor-a protein levels were quantitated by using a 0–5 scale
(O¼lowest and 5¼highest) to determine the percentile of cells
showing nuclear staining, and a 0–3 scale to determine the
staining intensity. The average scores for percentile cells stained
and staining intensity were added together separately in lobules
and ducts.
We also investigated the validity of our quantification method.
This was done by determining ER-a levels in 8-week-old
nontreated rats that were randomly divided to three groups
(n¼5 each). If significant differences were found among the
groups that should be similar (all nontreated animals), this would
suggest that our approach did not reliably predict the true
differences between the control and experimental mammary
glands.
Effects on offspring’s mammary tumorigenesis
Mammary tumours were induced by administration of 10mg
(B50mgkg
 1 body weight) 7,12-dimethylbenz(a)anthracene
(DMBA) (Sigma, St Louis, MO, USA) to 47-day-old female rats
(n¼23–25 per group) (Workman et al, 1998). The histopathology,
oestrogen dependence, oestrogen and progesterone receptor
expression and antioestrogen responsiveness of the DMBA-
induced tumours closely reflect human breast cancer (Russo and
Russo, 1987). More than 75% of the tumours induced by 10mg
DMBA are adenocarcinomas (Russo and Russo, 1996); in our
previous experiments, the proportion of adenocarcinomas in the
DMBA control group was 80–100% (Hilakivi-Clarke et al, 2000).
The carcinogen was dissolved in peanut oil and administered by
oral gavage in a volume of 1ml.
The animals were examined for mammary tumours by palpation
once per week. The end points for data analysis were: (i) latency to
tumour appearance, (ii) the number of animals with tumours
(tumour incidence), (iii) the number of tumours per animal
(tumour multiplicity) and (iv) tumour growth rate. During the
follow-up, those animals in which tumour burden approximated
10% of total body weight were killed, as required by our
institution. All surviving animals, including those that did not
appear to develop mammary tumours, were killed 17 weeks after
carcinogen administration.
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Results for the data obtained on: (i) pregnancy-related parameters
(pregnancy weight gain, birth weight, number of pups per litter
and pregnancy serum E2 levels); (ii) mammary gland morphology
(total number of TEBs and density of epithelial tree, ABs and
lobules in the whole mounts), (iii) ER-a protein levels and (iv)
some mammary tumour end points (latency and multiplicity) were
analysed using one- or two-way analysis of variance (ANOVA).
When determining latency, only the week when the first tumour
was detected was assessed. Animals that did not develop tumours
were included in the analysis and given a latency value of the
length of follow-up plus one week (18 weeks). When assessing
tumour multiplicity, animals that did not develop any tumours
were given a value 0. Where appropriate, between-group
comparisons were done using Fisher’s least significant difference
(LDS) test. Differences in the tumour incidence on week 17 were
determined using a w
2 test. The time to tumour presentation was
measured as the number of weeks from DMBA exposure to the
time the first tumour per animal could be palpated. Estimations of
tumour presentation were calculated by the methods developed by
Kaplan and Meier (1958). Differences among the treatment arms
were tested using an extension of the log rank test and both
Gehan’s and Peto’s generalised Wilcoxon tests as implemented in
STATISTICA (Stat soft, 1998). The differences were considered
significant if the P-value was less than 0.05. All probabilities are
two-tailed.
RESULTS
Effects on pregnancy outcome and pregnancy E2 levels
Maternal alcohol exposure did not affect the litter size, birth weight
or postnatal weight gain (data not shown). Vaginal opening of the
female pups, reflecting puberty onset, was not either affected by in
utero alcohol exposures (data not shown).
The E2 levels were significantly higher in the pregnant dams
consuming 16g alcohol than in the controls (Po0.05;
F(2,27)¼7.3, Po0.003) (Figure 1). The difference between the
controls and moderate-alcohol-exposed group (25g alcohol per kg
feed) did not reach statistical significance.
Effects on offspring’s mammary tumorigenesis
Tumour multiplicity (the total number of palpable tumours per
animal) was significantly higher in the rats exposed in utero to
alcohol than in the controls (F(2,69)¼5.53, Po0.006) (Figure 2A
and B). Post hoc analysis revealed that the increase was significant
between the control and moderate-alcohol groups. The tumour
incidence in all groups approached 100% and, therefore, no
differences in this end point among in utero alcohol-exposed and
control rats were seen. However, the incidence was consistently
higher in the alcohol groups than controls during each of the 17
weeks of tumour growth monitoring (Figure 2c).
Latency to the appearance of the first tumour was longer in the
control group, though not significantly so (mean7s.e.m. weeks,
control: 9.770.6, 16g alcohol: 8.470.5, 25g alcohol: 8.670.5).
Latency to any subsequent tumours (control: 10.570.4, 16g
alcohol: 9.770.3, 25g alcohol: 10.270.3) was not significantly
different among the groups. Further, tumour growth rates were
































16 g kg−1 feed alcohol 25 g kg−1 feed alcohol Control
Effect of alcohol on serum E2 levels 
on gestation day 19
Figure 1 Circulating oestradiol (E2) levels on gestation day 19 in rats fed
0g (control), 16g or 25g alcoholkg
 1 feed between gestation days 7 and
19. The E2 levels were significantly higher in the animals consuming 16g












































































16 g kg−1 feed alcohol
25 g kg−1 feed 
      alcohol
25 g kg−1 feed alcohol
16 g kg−1 feed 
      alcohol
Control
Weeks after DMBA administration
Control
Figure 2 Mammary tumour multiplicity (number of tumours per animal
at sacrifice) and total number of tumours per week in rats exposed in utero
to 0g (control, n¼24), 16g (n¼25) or 25g (n¼23) alcoholkg
 1 feed,
following an exposure to 10mg 7,12-dimethylbenz(a)anthracene (DMBA)
on postnatal day 47. The data shown for total number of tumours are
standardised to 24 animals per group, using the formula: 24  total number
of tumours per week, divided by the number of animals per group. These
latter data are shown to illustrate the differences among groups, and thus
were not subjected to statistical analysis. Tumour multiplicity was increased
in the 25gkg
 1 feed alcohol-exposed rats, compared to the controls:
*Po0.05.
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In utero exposure to alcohol increased epithelial density
(F(2,24)¼7.21, Po0.004) and the density of alveolar buds
(F(2,24)¼8.88, Po0.001), determined in 8- and 22-week-old rats
(Figures 3a and b). No changes were noted in the density of lobules
(data not shown). The total number of TEBs, assessed in
wholemounts of 3-, 6- and 8-week-old rats, was dose-dependently
increased during weeks 6 and 8 (F(2,39)¼12.6, Po0.001)
(Figure 3c). Representative wholemounts of the fourth abdominal
gland in 22-week-old offspring of dams exposed to control, low
(16gkg
 1 feed) and moderate (25gkg
 1 feed) alcohol during
pregnancy are also shown (Figure 3d). Our findings indicate that
in utero alcohol exposure increases mammary epithelial density
and the number of targets for malignant transformation.
Oestrogen receptor-a The validation study that determined ER-a

































































  feed 
 alcohol
25 g kg−1
  feed 
alcohol
Control 16    
 
25 g kg−1





  feed 
alcohol
Control 16   25 g kg−1
  feed 
alcohol
Control 16 g kg−1
  feed 
 alcohol
25 g kg−1
  feed 
alcohol
Control
8 weeks 22 weeks
16 g kg−1
  feed 
 alcohol
25 g kg−1
  feed 
alcohol
Control 16 g kg−1
  feed 
 alcohol
25 g kg−1

















16 g kg−1 feed alcohol 25 g kg−1 feed alcohol
A B
C
3 weeks 6 weeks 8 weeks
Figure 3 In utero exposure to 0g (control), 16g or 25g alcoholkg
 1 feed increase in (A) epithelial density and (B) the density of alveolar buds,
determined in 8- and 22-week-old rats. No changes were noted in the density of lobules. The total number of (C) TEBs, assessed in wholemounts of 3-, 6-
and 8-week-old rats, was also dose-dependently increased. Statistically different from the controls: *Po0.05. Representative wholemounts of the fourth
abdominal gland in 22-week-old offspring are shown.
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sof three similar groups of nontreated animals showed no
differences in either the lobular or ductal ER-a expression among
the groups. The proportion of cells stained and staining intensity
in the nontreated animals in three lobular and three ductal
structures per gland were evaluated using scales of 0–5 and 0–3,
respectively. The combined scores in the lobules of the three
nontreated groups were 3.370.2, 3.470.2 and 3.870.2, and in the
ducts 3.770.3, 3.270.3 and 3.270.2. These results suggest that
our quantitative approach for immunohistochemical assays is
unlikely to yield false-positive results.
We then determined ER-a expression in the mammary glands of
22-week-old rats exposed in utero to 0, 16 or 25g alcoholkg
 1 feed.
The results showed that the levels of ER-a protein were elevated in
the mammary gland of the rats exposed to alcohol in utero (ER-a
(F(2,18)¼3.9, Po0.04) (Figures 4a and b). These changes were
dose-dependent and significant only in the offspring of dams
consuming 25g alcoholkg
 1 feed-containing diets during preg-
nancy, when compared to the controls.
DISCUSSION
Many dietary factors are suggested to be linked to either increased
or reduced breast cancer risk, but the data supporting these
associations are mostly contradictory. Alcohol consumption is an
exception, and there is a consensus that alcohol intake increases
the risk of developing breast cancer (Smith-Warner et al, 1998;
Singletary and Gapstur, 2001; Hamajima et al, 2002). Some
epidemiological studies suggest that alcohol drinking during
adolescence and early adulthood has the strongest impact on
breast cancer risk (Harvey et al, 1987; Hiatt et al, 1988; Young,
1989; Garland et al, 1999), while results of some studies indicate
that drinking later in life increases breast cancer risk most
(Longnecker et al, 1995; Swanson et al, 1997). Data obtained in the
present study suggest that alcohol exposure already in utero
through a pregnant mother may increase breast cancer risk.
The idea that some breast cancers are pre-initiated in utero is
supported by several indirect observations in human populations.
These studies show that women who were exposed to high foetal
oestrogenic environment; that is, had a high birth weight or are
twins, are at an increased risk of developing breast cancer (Braun
et al, 1995; Michels et al, 1996; Sanderson et al, 1996; Weiss et al,
1997). At a particularly high risk are twins whose birth weight was
high (Hubinette et al, 2001). A recent study also found that women
exposed to the synthetic oestrogen diethylstilbestrol (DES) in utero
are at an increased risk of developing breast cancer (Palmer et al,
2002). Animal studies support the hypothesis. In rats, maternal
exposure to either oestradiol or DES increases the offspring’s
breast cancer risk (Walker, 1984; Hilakivi-Clarke et al, 1997b).
We found that maternal exposure to relatively low alcohol levels
increased pregnancy E2 levels in rats. Previous human studies have
shown that both acute and chronic alcohol consumption increases
circulating E2 levels in non-pregnant women (Hankinson et al,
1995), possibly by alcohol-induced increase in aromatase activity
(Purohit, 2000). A positive association between alcohol intake
during pregnancy and pregnancy oestrogen levels in humans has
also been reported (Petridou et al, 1992; Wuu et al, 2002). Thus,
the present data in animals and earlier data in humans show that
maternal alcohol consumption increases pregnancy E2 levels.
However, since the dams kept on the highest alcohol diet did not
show a significant increase in pregnancy E2 levels, although this
group showed most differences in tumorigenesis, it remains to be
determined whether the increased oestrogenicity in alcohol-
exposed pregnant dams explains their offspring’s increased
mammary tumorigenesis.
The mechanisms mediating the effect of in utero alcohol
exposure on mammary tumorigenesis may be linked to changes
in mammary gland morphology and gene expression. Oestrogens
stimulate normal mammary epithelial and tumour cell prolifera-
tion (Nandi et al, 1995), also when administered neonatally
(Hilakivi-Clarke et al, 1997a, b). In vitro and in vivo studies show
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Figure 4 In utero exposure to 0g (control), 16g or 25g alcoholkg
 1 feed increased oestrogen receptor (ER)-a levels in the mammary glands of 22-week-
old rats. Statistically different from the controls: *Po0.05. Representative sections of each of the three treatment groups for ER-a staining are shown.
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sproliferation (Singletary et al, 2001). In humans, alcohol is
associated with increased mammographic density (Vachon et al,
2000), and increased density is linked to four- to six-fold increase
in breast cancer risk (Boyd et al, 2001). These findings suggest that
elevated oestrogen levels in utero may have led to increased
mammary epithelial density seen in rats exposed to alcohol in
utero, and the increased density in turn increased the risk of
developing mammary tumours.
Earlier studies have reported that rats exposed to diets
containing 15–20% of energy from alcohol as juveniles exhibit
an increased number of TEBs and reduced lobular and alveolar
bud structures in their mammary glands (Singletary et al, 1991).
We found that rats exposed to alcohol in utero had an increased
number of TEBs, suggesting that alcohol exposure during foetal life
modifies the pathways controlling development of the mammary
gland. Further, since TEBs are targets for malignant transforma-
tion (Russo and Russo, 1987), their increased presence could
explain why alcohol increases mammary tumorigenesis.
In addition to affecting mammary gland morphology, in utero
alcohol exposure was found to increase the expression of ER-a in
the mammary gland, consistent with earlier in vitro data (Fan et al,
2000; Singletary et al, 2001) and data showing that the level of
alcohol intake correlates with ER-a expression in human breast
tumours (Enger et al, 1999). Activation of ER-a induces
proliferation of normal and malignant breast cells, and is
associated with promotion of breast cancer (Tonetti and Jordan,
1999). If ER-a is important in mediating the effects of in utero
alcohol exposure in increasing breast cancer risk, its levels should
be elevated in women who develop breast cancer. This assumption
is supported by findings showing that normal cells in the breasts
containing a tumour express higher levels of ER-a than the cells in
the breast containing a benign lesion (Khan et al, 1998). Further,
breast ER-a levels are significantly lower in the Asian women
exhibiting a low breast cancer risk than in the Caucasian women
exhibiting a high breast cancer risk (Lawson et al, 1999).
Findings obtained in this study showing that maternal alcohol
intake increased offspring’s mammary tumorigenesis suggest that
the role of maternal diet in modifying pregnancy oestrogen levels
and affecting daughter’s breast cancer risk should be investigated
further. Since oestrogen levels vary by four- to six-fold among
women undergoing normal pregnancy, and the reasons for the
variability remain poorly understood, it is essential to identify
dietary factors that modify pregnancy oestrogen levels and could
therefore potentially affect daughter’s breast cancer risk. Alcohol
might be one of these factors. It has been known for some time that
maternal alcohol consumption during pregnancy can cause FAS
or its less severe manifestation, foetal alcohol effects in the
offspring. The fact that maternal alcohol intake at levels that are
considerable lower than those inducing FAS might also increase
daughter’s breast cancer risk gives further weight to the
recommendation that women should avoid consuming alcohol
during pregnancy.
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